AMANTA HEALTHCARE LIMITED
Latest filings
Next results: Tue, 3 Nov · Financial Results- Board meeting set for November 3 financial results · Board & Shareholder Meetings
- Reg 74(5) Certificate filed for Q2 FY26-27 · Compliance
- Amanta Healthcare promoter group member gifts 4.46 percent stake to nephew · Ownership Changes
Snapshot
What the business is, and whether it's a good one at a fair price.
Manufactures IV fluid bottles and Small Volume Parenterals (SVP) for pharmaceutical and healthcare use. The SteriPort range uses ISBM (Injection Stretch Blow Moulding) technology to make two-port IV fluid bottles and contributes 42% of FY26 revenue; a third SteriPort line is being commissioned to roughly double annual capacity. The SVP portfolio covers inhalation and ophthalmic products. Materials are the largest cost line at 33.7% of revenue, with polymer price increases of 60-70% passed through via 5-6% selling price increases. FY26 revenue stood at INR288 crore with EBITDA of INR63 crore (22% margin) and PAT of INR15 crore.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Strengths
Nothing stands out in the filed numbers.Concerns
Charts
How has the market priced it — with filings on the timeline?
AMANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from AMANTA HEALTHCARE LIMITED's filed financials and exchange disclosures
What does AMANTA HEALTHCARE LIMITED do?
AMANTA HEALTHCARE LIMITED is a Pharmaceuticals & Biotechnology company listed on NSE and BSE, trading under the symbol AMANTA.
Is AMANTA HEALTHCARE LIMITED profitable?
Yes. Over the trailing twelve months AMANTA HEALTHCARE LIMITED reported a net profit of ₹15 Cr on revenue of ₹291 Cr.
Does AMANTA HEALTHCARE LIMITED pay a dividend?
Yes. The dividend yield is 0.07% at the current price. It paid out 3% of its profit as dividend in FY26.
Is AMANTA HEALTHCARE LIMITED debt-free?
No. It reported borrowings of ₹234 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹153 Cr after cash. Debt stands at 1.06× equity. That is higher than 94% of its 166 Pharmaceuticals peers.
Is AMANTA HEALTHCARE LIMITED expensive compared with its peers?
On trailing P/E, AMANTA HEALTHCARE LIMITED ranks 101 of 158 in Pharmaceuticals — cheaper than 36% of them, against an industry median of 30.1×. This is a position, not a valuation judgement.
How much does the AMANTA HEALTHCARE LIMITED share price move in a day?
On a typical session AMANTA HEALTHCARE LIMITED moves 1.99% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
When are AMANTA HEALTHCARE LIMITED's next results?
Financial Results on Tue, 3 Nov. MarketPing alerts you on WhatsApp the moment the filing lands.
Where can I track AMANTA HEALTHCARE LIMITED's announcements?
Every NSE and BSE filing by AMANTA HEALTHCARE LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.